Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma
- 1 May 2003
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 17 (5) , 987-990
- https://doi.org/10.1038/sj.leu.2402858
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphomaLeukemia, 2003
- Serum nm23-H1 Protein as a Prognostic Factor in Hematological MalignanciesLeukemia & Lymphoma, 2002
- Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphomaBlood, 2001
- Prognostic Implications of the Differentiation Inhibitory Factornm23-H1 Protein in the Plasma of Aggressive Non-Hodgkin’s LymphomaBlood, 1999
- Decrease in Nucleoside Diphosphate Kinase (NDPK/nm23) Expression during Hematopoietic MaturationJournal of Biological Chemistry, 1998
- Down-regulation of thenm23.h1 gene inhibits cell proliferationInternational Journal of Cancer, 1997
- Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines.Nature Medicine, 1997
- A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activityFEBS Letters, 1995